Profiel
Tracey Vetterick worked as Director at Biohealth Innovation, Inc. Ms. Vetterick worked at AstraZeneca PLC from 2011 to 2021, serving as Principal from 2011 to 2019.
Ms. Vetterick worked at Akebia Therapeutics, Inc. from 2021 to 2025, serving as VP-Portfolio Strategy & Corporate Administration from 2022 to 2025.
Ms. Vetterick completed graduate education at Northwestern University and undergraduate education at Miami University.
Eerdere bekende functies van Tracey Vetterick
| Bedrijven | Functie | Einde |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Hoofd Administratief Officier | 01-09-2025 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01-04-2021 |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth | Directeur/Bestuurslid | - |
Opleiding van Tracey Vetterick
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Miami University
Miami University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akebia Therapeutics, Inc.
Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth | Finance |
















